Illinois receives $1.3 million in drug misrepresentation settlement

CHICAGO - A $35 million settlement has been reached between 42 states and a pharmaceutical company over the marketing of an organ-transplant drug.

Illinois was among the 42 states involved in the settlement with Pfizer Inc., the parent company of Wyeth Pharmaceuticals Inc.  The state will receive $1.3 million from the settlement.

The settlement resolves allegations that Wyeth misrepresented the uses of the drug Rapamune, which was approved to help prevent the rejection of kidney transplants.  The states allege that Wyeth promoted Rapamune to doctors for uses following other organ transplants.

In a statement released by Illinois Attorney General Lisa Madigan on Wednesday, she says that "promoting drugs for unapproved uses is a potentially deadly practice."

Pfizer also released a statement, saying that the alleged activity occurred before it acquired Wyeth, and did not admit liability or wrongdoing as part of the settlement.

Current Conditions
  • Current Events